Bespoke Extracts (BSPK) Net Cash Flow Growth (1y) (2012 - 2025)
Bespoke Extracts (BSPK) Net Cash Flow Growth (1y) (2012 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.15 Bn | 87.28 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.85 Bn | 32.11 Bn | 1.97 Bn | 112.26% |
| 3 | Zoetis | 32.52 Bn | 30.58 Bn | 1.62 Bn | -44.11% |
| 4 | Takeda Pharmaceutical | 27.53 Bn | 23.47 Bn | 4.39 Bn | 209.30% |
| 5 | United Therapeutics | 23.21 Bn | 21.06 Bn | 648.10 Mn | -236.85% |
| 6 | RedHill Biopharma | 21.76 Bn | 21.76 Bn | - | - |
| 7 | Viatris | 20.30 Bn | 18.50 Bn | 1.16 Bn | 13,485.29% |
| 8 | Neurocrine Biosciences | 17.74 Bn | 16.42 Bn | 800.70 Mn | -1,047.81% |
| 9 | Elanco Animal Health | 12.59 Bn | 12.16 Bn | 785.00 Mn | -1,020.00% |
| 10 | Bespoke Extracts | 1.12 Mn | 1.11 Mn | 234,175.00 | 559.65% |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 559.65% |
| Jun 30, 2025 | -379.54% |
| Mar 31, 2025 | -483.40% |
| Dec 31, 2024 | 488.16% |
| Sep 30, 2024 | -71.85% |
| Jun 30, 2024 | 529.07% |
| Mar 31, 2024 | 138.91% |
| Dec 31, 2023 | -51.33% |
| Sep 30, 2023 | 99.58% |
| Jun 30, 2023 | -100.64% |
| Mar 31, 2023 | 62.77% |
| Nov 30, 2021 | -103.71% |
| May 31, 2021 | -832.80% |
| Feb 28, 2021 | 762.84% |
| Nov 30, 2020 | 84.06% |
| May 31, 2020 | -1,123.18% |
| Feb 29, 2020 | -788.60% |
| Nov 30, 2019 | 107.61% |
| Aug 31, 2019 | 55.85% |
| May 31, 2019 | -94.99% |